Advanced search
Publication Cover
Current Medical Research and Opinion Volume 20, 2004 - Issue 4
Submit an article Journal homepage
126
Views
7
CrossRef citations to date
0
Altmetric
Review Article

Transitioning pharmacologic therapy from oral agents to insulin for type 2 diabetes

Robert J. Tanenberg Diabetes and Obesity Center, East Carolina University, Greenville, NC, USACorrespondence[email protected]
Pages 541-553 | Accepted 15 Dec 2003, Published online: 01 Mar 2004

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Stephen Brunton. (2009) Implementing Treatment Guidelines for Type 2 Diabetes in Primary Care. Postgraduate Medicine 121:2, pages 125-138.
Read now

Articles from other publishers (6)

Elena L. Paley. 2023. Microbiome Metabolome Brain Vagus Nerve Circuit in Disease and Recovery. Microbiome Metabolome Brain Vagus Nerve Circuit in Disease and Recovery 501 513 .
Yongyi Wang, Jianggui Shan, Wengang Yang, Hui Zheng & Song Xue. (2013) High Mobility Group Box 1 (HMGB1) Mediates High-Glucose-Induced Calcification in Vascular Smooth Muscle Cells of Saphenous Veins. Inflammation 36:6, pages 1592-1604.
Crossref
Mariko OishiHiroki YokoyamaNobuyuki AbeKouichi IwasakiFuminobu OkuguchiKoichi KawaiHidekatsu SugimtoHiroshi TakamuraHiroshi TakedaKunihiro DoiKouichi HiraoShunya Ikeda. (2011) Time and Costs of Insulin Treatment in the Care of Newly Registered Type 2 Diabetes Patients in Diabetes Clinics across Japan (JDDM 22). Japanese Clinical Medicine 2, pages JCM.S7736.
Crossref
Virginia Valentine. (2010) Insulin Initiation During a 20-Minute Office Visit: Part 2: Making It Happen. Diabetes Spectrum 23:4, pages 260-266.
Crossref
Luigi Meneghini. (2007) Why and How to Use Insulin Therapy Earlier in the Management of Type 2 Diabetes. Southern Medical Journal 100:2, pages 164-174.
Crossref
Marie Thearle & Anne Marie B Brillantes. (2005) Unique characteristics of the geriatric diabetic population and the role for therapeutic strategies that enhance glucagon-like peptide-1 activity. Current Opinion in Clinical Nutrition and Metabolic Care 8:1, pages 9-16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.